Cancers, Free Full-Text

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Cancer Survivor Photo Booth Props You Are My Hero Sign

Radical causes of cancer

Remission, cancer-free, no evidence of disease: What's the difference?

Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers - European Urology Focus

Cancer

I Am Cancer Free! - Cancer Free Gift - Pin

Cancer-Free Creations

Download or order free information booklets

Cancer Ribbon Colors: The Ultimate Guide

Cancer Text Magic, PDF

Stand Up To Cancer - Cancer Research Charity

Cancer traits - Personality characteristics of cancer star sign

Detection of HPV-16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. - Abstract - Europe PMC

Cancer - Wikipedia